BUDAPEST, Hungary, August 14, 2012 /PRNewswire/ --
ChemAxon, a leader in providing chemistry software for the biotechnology and pharmaceutical industries, announces that its free, open access, web-based chemistry search and extraction service, chemicalize.org, is now supported on touchscreen tablet PCs including Apple iPad and Android devices. This new version provides users with high resolution chemically-intelligent web search and extraction on the move.
Powered by ChemAxon technology and used by scientists worldwide, chemicalize.org identifies chemical names (SMILES, InChI, traditional and IUPAC names) on websites, in text and PDF files, converting them to 2D structures. Researchers can also calculate and explore a range of structure-based properties, search by structure in the ever expanding chemicalize.org knowledge-base, and search the internet to find all websites citing a particular chemical structure.
The new chemicalize.org features:
To try for yourself visit http://www.chemicalize.org
To discover more about how ChemAxon's leading edge cross platform solutions power modern cheminformatics and chemical communication, please visit http://www.chemaxon.com
ChemAxon is a leader in providing cheminformatics software development platforms and desktop applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. The company is privately owned with European headquarters in Budapest and sales and support offices in Europe, Japan and North America.
The ChemAxon logo is a trademark of ChemAxon Ltd. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.
Copyright©2012 PR Newswire.
All rights reserved